Innate Pharma SA had a revenue of 12.35M in the quarter ending Jun 30, 2024, with -42.43%. This bring the company's revenue in the last twelve months to 44.51M, Increased -49.19%. In the fiscal year ending Dec 31, 2023, Innate Pharma SA had annual revenue of 51.90M with 4.56% growth.